Publications by authors named "Nathan Pennell"

Claim this Profile
L
Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study.
Heya Batah, Emily C Zabor, Bridget Adcock, Monica Lee, Preeyal Patel, Nathan A Pennell

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Return to Intended Oncologic Therapy in Patients With Metastatic Non-Small Cell Lung Cancer Discharged to a Skilled Nursing Facility.
Anirudh Yalamanchali, Preeyal Patel, Ali Mushtaq, Renato Samala, Nathan A Pennell

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).
Shirish M Gadgeel, Misako Nagasaka, Karen Dziubek, Thomas Braun, Khaled Hassan, Nathan Pennell

Clin Lung Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancancer outcome prediction via a unified weakly supervised deep learning model.
Wei Yuan, Yijiang Chen, Biyue Zhu, Sen Yang, Jiayu Zhang, Nathan A Pennell

Signal Transduct Target Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taletrectinib in + Non-Small Cell Lung Cancer: TRUST.
Maurice Pérol, Wei Li, Nathan A Pennell, Geoffrey Liu, Yuichiro Ohe

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer.
Pranjal Vaidya, Mohammadhadi Khorrami, Kaustav Bera, Pingfu Fu, Lukas Delasos, Nathan A Pennell

NPJ Precis Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer.
Marcia S Brose, C Benedikt Westphalen, Xiaoyun Pan, Vadim Bernard-Gauthier, Milena Kurtinecz, Nathan A Pennell

JCO Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Nathan A Pennell

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of selpercatinib for Rearranged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over time.
Luis E Raez, Ashish C Massey, Scott S Barker, Patrick M Peterson, Katherine Liming, Nathan A Pennell

Oncologist· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC.
Lukas Delasos, Mohammadhadi Khorrami, Vidya S Viswanathan, Khalid Jazieh, Yifu Ding, Nathan A Pennell

NPJ Precis Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Nathan A Pennell

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutation testing, treatment and survival in stage I-III non-small cell lung cancer: CancerLinQ Discovery database retrospective analysis.
Bharathi Muthusamy, Mehmet Berktas, Jingyi Li, Darren S Thomas, Ping Sun, Nathan A Pennell

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for pembrolizumab stratified by pemetrexed maintenance post pembrolizumab-platinum-pemetrexed induction in metastatic non-small-cell lung cancer.
Jerome H Goldschmidt, Srinivas Annavarapu, Divea Venkatasetty, Yunfei Wang, Melissa L Santorelli, Nathan A Pennell

Immunotherapy· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from ADAURA: Can we improve on a positive trial?
Howard Jack West, Nathan A Pennell

Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab.
Lukas Delasos, Wei Wei, Khaled A Hassan, Nathan A Pennell, Pradnya Patil

Clin Lung Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAURA update: only the end of the beginning.
Bharathi Muthusamy, Nathan A Pennell

Transl Lung Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Nomogram Using Novel Computed Tomography-Based Radiomics Predicts Survival in Patients With Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
Eashwar Somasundaram, Raoul R Wadhwa, Adam Litzler, Rowan Barker-Clarke, Peng Qi, Nathan A Pennell

JCO Clin Cancer Inform· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.
Arvind Ravi, Matthew D Hellmann, Monica B Arniella, Mark Holton, Samuel S Freeman, Nathan A Pennell

Nat Genet· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma.
Bharathi Muthusamy, Kira Raskina, Katherine T Lofgren, Gerald Li, Khaled Tolba, Nathan Pennell

J Thorac Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States.
Christopher A Lemmon, Jie Zhou, Brian Hobbs, Nathan A Pennell

JCO Precis Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRUST-II: a global phase II study of taletrectinib in -positive non-small-cell lung cancer and other solid tumors.
Misako Nagasaka, Yuichiro Ohe, Caicun Zhou, Chang-Min Choi, Nong Yang, Nathan A Pennell

Future Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal predictive probability designs for randomized biomarker-guided oncology trials.
Emily C Zabor, Alexander M Kaizer, Nathan A Pennell, Brian P Hobbs

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181.
John Michael Varlotto, Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Thomas J Fitzgerald, Nathan A Pennell

Clin Lung Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer.
Bharathi Muthusamy, Pradnya D Patil, Nathan A Pennell

J Natl Compr Canc Netw· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Socioeconomic Factors on Overall Survival in SCLC.
Logan Roof, Wei Wei, Katherine Tullio, Nathan A Pennell, James P Stevenson

JTO Clin Res Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis